News & Events

PRESS RELEASE: Optellum Receives FDA Clearance for the World’s First AI-Powered Clinical Decision Support Software for Early Lung Cancer Diagnosis

• Post published:March 23, 2021
• Post category:Clinical/News

Virtual Nodule Clinic empowers clinicians to make optimal clinical decisions in early-stage lung cancer diagnosis and is now commercially available in the United States. Oxford, United Kingdom – March 23,…

Continue Reading PRESS RELEASE: Optellum Receives FDA Clearance for the World’s First AI-Powered Clinical Decision Support Software for Early Lung Cancer Diagnosis

Optellum named by the UK government as one of the top 100 digital health companies

• Post published:March 2, 2021
• Post category:News/Partners

Healthcare UK, part of the Department for International Trade (DIT), has launched a programme to showcase the UK's leading digital health companies.  Digital Health and Artificial Intelligence is seen as the answer to many of the challenges facing global…

Continue Reading Optellum named by the UK government as one of the top 100 digital health companies

Optellum’s year in review

• Post published:January 15, 2021
• Post category:Advisors/Clinical/Investment/News/Partners/Team

2020 was an extraordinary year and, looking back, while it was dominated by the world health crisis of the pandemic there were also colossal achievements in healthcare and medical technology;…

Continue Reading Optellum’s year in review

Optellum expands its commercial team in readiness for US sales

• Post published:December 29, 2020
• Post category:News/Team

In recent months, three new appointments have expanded the Optellum team to grow commercial adoption of the Optellum Virtual Nodule Clinic software in the USA. Ryan Hennen (VP of US Sales)…

Continue Reading Optellum expands its commercial team in readiness for US sales

Optellum set to take off in 2021 according to Business Insider

• Post published:December 23, 2020
• Post category:Investment/News

Business Insider highlights Optellum amongst top healthcare start-ups that are heating up and set to take off in 2021. Business Insider interviewed dozens of venture capitalists and other private investors to learn which…

Continue Reading Optellum set to take off in 2021 according to Business Insider

Clinical study demonstrates benefit of Optellum AI-assisted diagnosis for lung cancer

• Post published:December 21, 2020
• Post category:Clinical/News

Dr Vachani presented a virtual poster as a three-minute video as part of a session that highlighted lung cancer projects across the continuum of care.

Continue Reading Clinical study demonstrates benefit of Optellum AI-assisted diagnosis for lung cancer

Optellum partners with University of Oxford in £11 million AI programme to accelerate lung cancer diagnosis

• Post published:July 7, 2020
• Post category:News/Partners

Optellum is proud to be a key industry partner in a £11M University of Oxford-led AI programme to accelerate lung cancer diagnosis. NHS England and three industry leaders, Optellum, Roche,…

Continue Reading Optellum partners with University of Oxford in £11 million AI programme to accelerate lung cancer diagnosis

Optellum’s lung cancer prediction AI is clinically validated in the top-ranked US respiratory journal

• Post published:April 30, 2020
• Post category:Clinical/News

Global leading doctors from Vanderbilt and Oxford have published independent clinical validation of the Optellum Lung Cancer Prediction AI, illustrating its potential to shorten time to diagnosis. The paper, with…

Continue Reading Optellum’s lung cancer prediction AI is clinically validated in the top-ranked US respiratory journal

Optellum’s lung cancer prediction AI is clinically validated in Thorax

• Post published:March 5, 2020
• Post category:Clinical/News

The Optellum artificial intelligence prediction model has been demonstrated to outperform the best currently used model. Prediction of the likelihood of malignancy is central to the clinical management of suspicious…

Continue Reading Optellum’s lung cancer prediction AI is clinically validated in Thorax

New Appointments Strengthen Leadership Team

• Post published:February 13, 2020
• Post category:News/Team

Optellum has strengthened leadership team to support the commercialisation and clinical validation of its first product, and the development of product pipeline in the treatment of lung cancer and other…

Continue Reading New Appointments Strengthen Leadership Team

Prof Sir Michael Brady at the Mohamed bin Zayed University of Artificial Intelligence

Optellum co-founder helps start the world’s first AI university.

• Post published:October 17, 2019
• Post category:News

Optellum Chairman & co-founder, Prof. Sir Michael Brady FRS (center), is named the founding Board of Trustees member, and the interim President of the world's first AI University. Prof Sir…

Continue Reading Optellum co-founder helps start the world’s first AI university.

Optellum at AI@Oxford Conference

• Post published:September 18, 2019
• Post category:News

Optellum Founder and Chief Science & Technology Officer will share the lessons learned by Optellum in enabling early lung cancer diagnosis & treatment at the AI@Oxford congress. University of Oxford…

Continue Reading Optellum at AI@Oxford Conference